29.03.2016 Views

DPCA 1-2 full issue

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

NOW<br />

PBS LISTED<br />

Introducing<br />

The fixed dose combination of<br />

JARDIANCE ® + metformin 1<br />

(empagliflozin)<br />

JARDIAMET ® and JARDIANCE ® ,<br />

Now PBS listed for: 2<br />

✔ Dual therapy<br />

(empagliflozin + metformin OR SU)<br />

✔ Triple therapy<br />

(empagliflozin + metformin AND SU)<br />

NEW<br />

✔ Add-on to insulin<br />

NEW<br />

INSULIN<br />

DUAL<br />

PBS<br />

LISTED<br />

TRIPLE<br />

Fictitious patient<br />

JARDIANCE ® is an SGLT2 inhibitor for adult patients<br />

with inadequately controlled type 2 diabetes. 3<br />

THAT SOUNDS<br />

GOOD TO<br />

DOCTOR<br />

PBS Information: JARDIANCE ® and JARDIAMET JARDIANCE ® : Authority ® is Required an SGLT2 inhibitor (STREAMLINED). for adult patients<br />

with inadequately controlled type 2 diabetes.<br />

Type 2 Diabetes. Refer to PBS Schedule for <strong>full</strong> Authority Required Information.<br />

3<br />

BEFORE PRESCRIBING, PLEASE REVIEW THE FULL PRODUCT INFORMATION WHICH IS AVAILABLE FROM<br />

WWW.BOEHRINGER-INGELHEIM.COM.AU/PI<br />

JARDIANCE ® PI<br />

JARDIAMET ® PI<br />

References: 1. JARDIAMET ® Product Information. 22 February 2016. 2. Schedule of Pharmaceutical Benefits. Available at: www.pbs.gov.au. Accessed March 2016. 3. JARDIANCE ®<br />

Product Information. 18 March 2016.<br />

Boehringer Ingelheim Pty Limited, ABN 52 000 452 308.<br />

78 Waterloo Road, North Ryde, NSW 2113 Australia. Copyright © 2016.<br />

ELI3690_ET_FP AU/EMP/00093d Prepared March 2016.<br />

Eli Lilly Australia Pty Limited, ABN 39 000 233 992.<br />

112 Wharf Road, West Ryde, NSW 2114 Australia.<br />

Copyright © 2016

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!